Li-qiong Yang - Publications

Vitamin B5 supports anti-PD1 response in HER2-positive gastric cancer and enhances interaction between naïve B cells and T cells.

Journal: Nature communications

Published: September 22, 2025

The novel BCL-2/BCL-XL inhibitor APG-1252-mediated cleavage of GSDME enhances the antitumor efficacy of HER2-targeted therapy in HER2-positive gastric cancer.

Journal: Acta pharmacologica Sinica

Published: June 21, 2024

APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma by suppressing MEK/ERK and CREB/Bcl-xl pathways.

Journal: International immunopharmacology

Published: May 07, 2024

Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: March 18, 2024

The relationship between brain metastasis and HER2 expression status in gastric cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 26, 2023

Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response.

Journal: Signal transduction and targeted therapy

Published: January 31, 2023

A novel nomogram integrated with PDL1 and CEA to predict the prognosis of patients with gastric cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 08, 2022